结合治疗与连续替代疗法和连续静脉注射输液治疗的临床影响
Akinori Yamaguchi1,2, Atsuyoshi Mita2, Kosuke Sonoda1,2
1Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
概括
连续替代疗法 (CRRT) 和连续静脉输注 (cIVNa) 的联合治疗改善了临床急性损伤 (AKI) 临床急性损伤患者的血液动力学和生存率. 这种方法为需要CRRT的AKI患者提供了有前途的治疗选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
- 内部医学 内部医学
背景情况:
- 患有前先性急性损伤 (AKI) 的重症患者经常经历不足的血补充.
- 连续脏替代疗法 (CRRT) 是在重症监护机构对AKI的常见治疗方法.
- 对于特定的AKI患者群体,将CRRT与持续静脉注 (cIVNa) 结合在一起的疗效仍然是研究领域.
研究的目的:
- 研究涉及CRRT和cIVNa的组合治疗的临床效应.
- 评估这种组合疗法对血动力学参数和前期AKI重病患者的生存结果的影响.
- 为了确定cIVNa是否可以增强CRRT在血充填不足的患者中所带来的益处.
主要方法:
- 一个单一中心的回顾性研究分析了92名重症患者的数据.
- 患者被分为两个组:单独CRRT (对照组,n=49) 和CRRT + cIVNa (干预组,n=43).
- 对照组和干预组进行了统计比较.
主要成果:
- 组合疗法显著增加了血压和尿液量,表明血液动力学稳定.
- 与对照组相比,干预组显示低血压事件显著减少.
- CRRT + cIVNa 组显著改善了90天生存率 (61.9%对38.8%),在60天和90天没有RRT的生存率,以及更高的重症监护病房生存率.
结论:
- 与CRRT和cIVNa的联合治疗似乎是一个有益的治疗策略.
- 这种方法可以改善血液动力学状况,并提高前期AKI的重症患者的生存结果.
- 与cIVNa结合的CRRT对于需要CRRT并且体验不足的血补充的先天AKI患者来说是一个潜在的有用选择.
更多相关视频
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
01:22Heart Failure Drugs: Diuretics
294
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
294
01:27Dialysis
231
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
231
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
407
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
407
01:11Renal Failure: Dose Adjustments
37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37
01:25Antihypertensive Drugs: Direct Renin Inhibitors
445
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
445